	Circulating cell-free DNA as an integrative biomarker in breast cancer: correlation with molecular subtypes, mutation status, and treatment response. Front Oncol Solanki R, Kaur A, Gothwal R, Lakhera KK, Kalal BS, Vijay U. PMID: 41788987 [PubMed]
	Evaluating the effect of using a mobile app on the management of chemotherapy side effects and quality of life in breast cancer patients: Protocol for a randomized controlled trial. J Educ Health Promot Raei Mehneh M, Kimiafar K, Mousavi Baigi SF, Marouzi P, Shahidsales S, Sarbaz M. PMID: 41788960 [PubMed]
	Relationships between social support and resilience of breast cancer patients in Indonesia: A cross-sectional study. J Educ Health Promot Pulungan RM, Helda H, Wahyono TYM, Sutandyo N. PMID: 41788944 [PubMed]
	Correction: Adherence with hormonal therapy in women with breast cancer: a cross-sectional study in Medellin, Colombia. Colomb Med (Cali) PMID: 41788894 [PubMed - in process]
	Fusion of genomic and pathological data for breast cancer detection using BCDNN. Front Med (Lausanne) Bilal A, Obidallah WJ, Wassan S, Albathan M, Almakki R, Alshaikh Z, Shafiq M. PMID: 41788706 [PubMed]
	Factors Influencing Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer: A Single-Center Retrospective Study Focusing on ER and HER-2 Status. Int J Breast Cancer Zhang Y, Qiu S, Wang X. PMID: 41788672 [PubMed]
	An exploratory serum metabolomics study for screening and staging of breast cancer. Gynecol Endocrinol Zou Y, Song D, Cai Y, Liang K, Fu J, Zhang H. PMID: 41787748 [PubMed - in process]
	Cancer-immunity cycle-based molecular subtypes in breast cancer predict the response to immune checkpoint inhibitors. Cancer Biol Med Shao D, Yu T, Xiao Y, Shao Z. PMID: 41787716 [PubMed - as supplied by publisher]
	IL3RA identified as novel biomarker and therapeutic target for ER(+) breast cancer through plasma proteome-wide mendelian randomization and TCGA database analysis. Clin Proteomics Mei H, Zhang Z, Jiang N, Lu W, Chang L, Song Q, Li F. PMID: 41787256 [PubMed - as supplied by publisher]
	Ovarian cancer. Nat Rev Dis Primers Scott CL, Banerjee S, Joly F, Lee JM, Mukhopadhyay A, Tan DS, Kohn EC. PMID: 41786760 [PubMed - in process]
	Global, regional, and national burden of breast cancer among females, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Oncol GBD 2023 Breast Cancer Collaborators. PMID: 41785894 [PubMed - in process]
	Imlunestrant plus abemaciclib versus fulvestrant plus abemaciclib in ER-positive, HER2-negative advanced breast cancer: an indirect treatment comparison of three phase III trials. ESMO Open Jhaveri K, Bidard FC, Kalinsky K, Neven P, Rugo HS, Tolaney SM, Litchfield LM, von Laue CC, Traore S, Sapunar F, Li Y, O'Shaughnessy J. PMID: 41785668 [PubMed - as supplied by publisher]
	Long-term benefit from adjuvant tamoxifen therapy for ER+ HER2- breast cancer by PR positivity. Int J Cancer Nordenskjöld AE, Ríos-Romero M, Dar H, Fornander T, Perez-Tenorio G, Fohlin H, Stål O, Tutzauer J, Lindström LS. PMID: 41787605 [PubMed - as supplied by publisher]
	Genetically predicted inflammatory cytokines mediate the associations between the gut microbiota and ovarian cancer: a bidirectional two-sample Mendelian randomization study. J Ovarian Res Chuan L, Yao B, Zhang H, Luo S, Lu G, Wu Y, Ren Y. PMID: 41787531 [PubMed - as supplied by publisher]
	DNA methylation-regulated AKAP12 expression modulates ECM remodeling and ADP/FAD ratio to influence prognosis in ovarian cancer. J Ovarian Res Ying Y, Zhang H, Ming J, Yu L, Wang F, Guo Z. PMID: 41787475 [PubMed - as supplied by publisher]
	Acceptance and commitment therapy improves the quality of life of breast cancer patients by reducing helplessness: a randomized controlled trial. BMC Palliat Care Song W, Shari NI, Abdullah MFILB, Hussin HB, Zhang R, Mansor NS. PMID: 41787365 [PubMed - as supplied by publisher]
	Prediction of Ki-67 expression in invasive breast cancer with dual-modality radiomics. Sci Rep Xu R, Lin Q, Zheng C, Fang W, Liu C, Lin J, Gao F, Zhang S, Ouyang Q, Zhou Y. PMID: 41786866 [PubMed - as supplied by publisher]
	Preoperative Prediction of Axillary Lymph Node Metastasis in Breast Cancer Using a Three-tier MRI Radiomics Model with Nested Cross-validation. Acad Radiol Li H, Huang W, Liang J, Huang S, Xu X, Shao B, Chen H. PMID: 41786550 [PubMed - as supplied by publisher]
	Impact of screening on late-stage breast cancer in the Netherlands: a population-based cohort study (2007-2016). Breast Lin Y, Sidorenkov G, Wang J, Greuter MJW, Houssami N, Dorrius MD, Siesling S, de Munck L, de Bock GH. PMID: 41785742 [PubMed - as supplied by publisher]
	Focusing on toxicity management: Challenges and strategies for HER2-targeted antibody-drug conjugates in breast cancer. Breast Liu X, Yin S, Li X, Nie J. PMID: 41785741 [PubMed - as supplied by publisher]

Articles 1 - 20 / 325189

Page 1 of 16260



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy